150 related articles for article (PubMed ID: 2880862)
61. Functional evaluation of the adenohypophysis with metoclopramide in hyperprolactinemic-amenorrheic women in relation to radiological findings on the sella turcica.
Seki K; Uesato T; Kato K; Shima K
Endocrinol Jpn; 1984 Dec; 31(6):733-9. PubMed ID: 6532792
[TBL] [Abstract][Full Text] [Related]
62. Responsiveness of gonadotropin secretion to infusion of an opiate-receptor antagonist in hypogonadotropic individuals.
Veldhuis JD; Kulin HE; Warner BA; Santner SJ
J Clin Endocrinol Metab; 1982 Oct; 55(4):649-53. PubMed ID: 6809778
[TBL] [Abstract][Full Text] [Related]
63. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
[TBL] [Abstract][Full Text] [Related]
64. [Effect of opioids and gamma-aminobutyric acid on ovulation].
Spremović-Radjenović S; Popović V; Matijasević S; Lazović G; Petković S
Srp Arh Celok Lek; 1997; 125(11-12):329-32. PubMed ID: 9480565
[TBL] [Abstract][Full Text] [Related]
65. Impairment of opioid control of luteinizing hormone secretion in menstrual disorders.
Petraglia F; D'Ambrogio G; Comitini G; Facchinetti F; Volpe A; Genazzani AR
Fertil Steril; 1985 Apr; 43(4):534-40. PubMed ID: 3886435
[TBL] [Abstract][Full Text] [Related]
66. Effects of nocturnal hyperprolactinemia on ovarian luteal function and galactorrhea.
Yamaguchi M; Aono T; Koike K; Nishikawa Y; Ikegami H; Miyake A; Tanizawa O
Eur J Obstet Gynecol Reprod Biol; 1991 May; 39(3):187-91. PubMed ID: 2032589
[TBL] [Abstract][Full Text] [Related]
67. Early normalization of luteinizing hormone pulsatility after successful transsphenoidal surgery in women with microprolactinomas.
Stevenaert A; Beckers A; Vandalem JL; Hennen G
J Clin Endocrinol Metab; 1986 May; 62(5):1044-7. PubMed ID: 3958122
[TBL] [Abstract][Full Text] [Related]
68. Treatment of hyperprolactinemic amenorrhea with Metergoline.
Bohnet HG; Kato K; Wolf AS
Obstet Gynecol; 1986 Feb; 67(2):249-52. PubMed ID: 3945435
[TBL] [Abstract][Full Text] [Related]
69. Modulation of tissue responsiveness to angiotensin-II in hyperprolactinemic subjects.
Arafah BM; Gordon NH; Salazar R; Douglas JG
J Clin Endocrinol Metab; 1990 Jul; 71(1):60-6. PubMed ID: 2370301
[TBL] [Abstract][Full Text] [Related]
70. Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
Moro M; Maraschini C; Cavagnini F
Gynecol Endocrinol; 1997 Jun; 11(3):155-62. PubMed ID: 9209895
[TBL] [Abstract][Full Text] [Related]
71. Twenty-four hour secretory pattern of thyroid-stimulating hormone in hyperprolactinemic women with pituitary microadenoma.
Seki K; Uesato T; Kato K; Shima K
Endocrinol Jpn; 1985 Jun; 32(3):369-73. PubMed ID: 4042992
[TBL] [Abstract][Full Text] [Related]
72. Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.
Coiro V; Volpi R; Gramellini D; Cigarini C; Magotti MG; Caffarri G; Chiodera P
Gynecol Obstet Invest; 1997; 43(3):162-5. PubMed ID: 9127128
[TBL] [Abstract][Full Text] [Related]
73. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
Schlechte J; Walkner L; Kathol M
J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
[TBL] [Abstract][Full Text] [Related]
74. Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
Serri O
Horm Res; 1987; 27(1):36-41. PubMed ID: 3623428
[TBL] [Abstract][Full Text] [Related]
75. Progestins increase endogenous opioid peptide activity in postmenopausal women.
Casper RF; Alapin-Rubillovitz S
J Clin Endocrinol Metab; 1985 Jan; 60(1):34-6. PubMed ID: 3155455
[TBL] [Abstract][Full Text] [Related]
76. Opioid control of luteinizing hormone secretion in patients with hirsutism and hyperandrogenemia.
Petraglia F; Golinelli S; d'Ambrogio G; Comitini G; Facchinetti F; Volpe A; Genazzani AR
Gynecol Obstet Invest; 1987; 23(2):117-21. PubMed ID: 3034748
[TBL] [Abstract][Full Text] [Related]
77. The role of opiate peptides in the mechanisms leading to the disturbances of pulsatile secretion of LH in hyperprolactinaemic women.
Baranowska B; Dorobek W; Misiorowski W; Jeske W
Endokrynol Pol; 1986; 37(1):1-10. PubMed ID: 2942395
[No Abstract] [Full Text] [Related]
78. [Effect of a histamine H2-receptor antagonist, cimetidine, on prolactin secretion in women].
Masaoka K; Niibe T; Kumasaka T; Saito M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1627-33. PubMed ID: 6619615
[TBL] [Abstract][Full Text] [Related]
79. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
[TBL] [Abstract][Full Text] [Related]
80. [The causes of infertility in hyperprolactinemia].
Speranskaia NV; Ovsiannikova TV; Kerova AN; Pshenichnikova TIa
Probl Endokrinol (Mosk); 1989; 35(5):18-24. PubMed ID: 2511569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
